Gilead Sciences (GILD) Debt/EBITDA US GAAP (year values) |
||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
Debt/EBITDA | 5.68 | 1.67 | -1.13 | 1.99 | 1.69 | 131.0 | ||
Changes by years, y/y, % | -3 546% | -71% | -168% | -277% | -15% |
Gilead Sciences. Debt/EBITDA
Gilead Sciences. Debt/EBITDA, changes, %
Gilead Sciences (GILD) Debt/EBITDA US GAAP (quarter values) |
||||||||
2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
Debt/EBITDA | 1.93 | 4.41 | 3.63 | -0.54 | 6.23 | 131.0 | ||
Changes by years, y/y, % | -4% | +119% | +87% | -129% | +238% | |||
Changes by quarters, q/q, % | +15% | +129% | -18% | -115% | -1 253% |